Related Experiment Video
Updated: Feb 20, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Does mitral valve repair matter in infants with ventricular septal defect combined with mitral regurgitation?
Yuriy Y Kulyabin1, Ilya A Soynov1, Alexey V Zubritskiy1
1Department of Pediatric Cardiac Surgery, Siberian Biomedical Research Center, Ministry of Health Russian Federation, Novosibirsk, Russian Federation.
Insights
Simultaneous mitral valve repair (MVR) offers no advantage for infants with ventricular septal defect (VSD) and mitral regurgitation (MR) compared to VSD closure alone. Mild residual MR post-surgery predicts future moderate to severe MR.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Cardiac Surgery Outcomes
Background:
- Ventricular septal defect (VSD) is a common congenital heart defect.
- Mitral regurgitation (MR) can coexist with VSD, complicating surgical management.
- The efficacy of simultaneous mitral valve repair (MVR) alongside VSD closure requires evaluation.
Purpose of the Study:
- To assess mid-term mitral valve function following combined VSD repair and MVR.
- To determine the clinical utility of performing MVR concurrently with VSD closure.
- To identify factors influencing mitral regurgitation progression post-surgery.
Main Methods:
- Retrospective analysis of 60 patients with VSD and MR from June 2005 to March 2014.
- Propensity score matching (1:1) created two groups: VSD closure with MVR (n=23) and VSD closure only (n=23).
- Mid-term follow-up (12-48 months) assessed mitral valve function and recurrence of MR.
Main Results:
- No significant difference in postoperative mortality or short-term recovery between groups.
- Longer cardiopulmonary bypass and aortic cross-clamping times were observed in the VSD+MVR group.
- No significant difference in freedom from moderate or severe MR (MR ≥ 2+) between groups.
- Mild residual MR in the early postoperative period was the sole significant predictor of recurrent MR ≥ 2+.
Conclusions:
- Simultaneous MVR provides no additional benefit over isolated VSD closure for patients with VSD and MR.
- The presence of mild residual MR postoperatively is a critical risk factor for developing significant MR during follow-up.
- Focusing on achieving complete early MR correction is crucial for long-term outcomes.
Objectives:
This study aimed to assess mitral valve function after repair of ventricular septal defect (VSD) combined with mitral regurgitation (MR) in the mid-term follow-up period, to evaluate the clinical utility of simultaneous mitral valve repair (MVR).
Methods:
From June 2005 to March 2014, 60 patients with VSD and MR underwent surgical treatment. After performing propensity score analysis (1:1) for the entire sample, 46 patients were selected and divided into 2 groups: those with VSD closure and MVR (VSD + MVR, 23 patients) and those with VSD closure without mitral valve intervention (VSD only, 23 patients). The follow-up period ranged from 12 to 48 months (median 32 months; interquartile range 28-40 months).
Results:
There was no postoperative mortality in either group. There was no significant difference in the duration of the postoperative period between groups (ventilation time, P = 0.49; inotropic support, P = 0.50). Mean cardiopulmonary bypass time and aortic cross-clamping time were significantly longer in the 'VSD + MVR' group (cardiopulmonary bypass, P = 0.023; aortic cross-clamp, P < 0.001). There was no significant difference in regurgitation area (P = 0.30) and MR grade (P = 0.76) between groups postoperatively. There was no significant difference in freedom from MR ≥ 2+ between groups (log-rank test, P = 0.28). In the 'VSD + MVR' group, 12-, 36- and 42-month freedom from MR ≥ 2+ values were 100%, 59 ± 10.4% [95% confidence interval (CI) 36.1-76.2%] and 44 ± 15% (95% CI 15.8-69.7%), respectively, while in the 'VSD only' group, these values were 100%, 54.5 ± 10.6% (95% CI 32-72.3%) and 54.5 ± 10.6% (95% CI 30-72.3%), respectively. The only significant risk factor for recurrent MR ≥ 2+ during the follow-up period was mild residual MR in the early postoperative period (P = 0.037).
Conclusions:
In infants with VSD combined with MR, simultaneous MVR has no benefits simultaneous MVR provided no advantage over that of isolated VSD closure. We found that the presence of mild residual MR in the early postoperative period predisposes the development of MR ≥ 2+ in follow-up period.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction
Mitral Stenosis III: Medical Management

